Proactive - Interviews for investors

Guardian Metal Resources CEO Oliver Friesen joined Steve Darling from Proactive to announce a major development at the company's flagship Pilot Mountain Project in Nevada, revealing potential large-scale porphyry-style mineralization. The discovery was made in drill hole PM24-002, prompting the company to consult with Dr. Lawrence Carter, a renowned expert in porphyry copper deposits and a specialist on the nearby Yerington porphyry copper district.

Dr. Carter conducted a comprehensive review and provided recommendations for further exploration and drilling. In response to these findings, Guardian Metal Resources has staked an additional 16 new claims at Pilot Mountain, significantly expanding the project's footprint. The company has also completed further magnetic and induced polarization (IP) geophysical surveys to aid in drill targeting. The results of these additional IP surveys will be interpreted and released in the near future, as the company continues to explore the potential of this promising mineralization.

#proactiveinvestors #guardianmetalrrsources #aim #gmet #otcqx #gmtlf

#Tungsten, #CriticalMetals, #Mining, #PilotMountain, #OliverFriesen, #USNationalSecurity, #PorphyryExploration, #GreenTechnologies, #NuclearFusion, #MilitaryApplications, #GeophysicalAnomaly, #DrCarter, #NevadaMining, #OTCListing, #UKCompany, #USMarket, #MineralSupplyChain, #Reshoring, #ExplorationGeology#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Tru Precious Metals CEO Joel Freudman joined Steve Darling from Proactive to share news about the company’s exciting announcement of a definitive earn-in agreement with Eldorado Gold Corporation. This agreement grants Eldorado an exclusive option to acquire an 80% ownership interest in TRU's Golden Rose Project, located in Central Newfoundland.

Freudman emphasized that the deal with Eldorado is a significant endorsement of the substantial work TRU has undertaken since acquiring the initial land package from Altius Minerals in 2021. To secure this 80% stake in the Golden Rose Project, Eldorado is required to make payments and fund exploration expenditures totaling up to 7 million dollars, along with additional cash considerations.

The company has already commenced its exploration program at Golden Rose, focusing on various methodologies including prospecting, grab sampling, reconnaissance soil sampling, and trenching. These activities target critical mineral anomalies identified through prior TRU investigations, historical data analysis, and newly acquired high-resolution satellite and remote sensing data covering the entire property. The Golden Rose Project is particularly notable for being historically underexplored, with many of the planned target areas experiencing limited previous exploration.

El Dorado must invest CAD 660,000 in drilling by July next year as part of their exploration commitments. TRU Precious Metals has already initiated preliminary fieldwork, focusing on copper exploration, to integrate copper drill targets with the gold-focused drill program. The company anticipates increased exploration activity and subsequent news flow in the coming months, marking a pivotal moment in its growth and operations.

#proactiveinvestors #trupreciousmetalscorp #tsxv #otcqb #truif #mining #goldenroseproject

#GoldenRoseProject, #Mining, #GoldMining, #CopperMining, #Newfoundland, #ElDoradoGold, #MineralExploration, #MiningIndustry, #PreciousMetals, #Gold, #Copper, #Drilling, #Exploration, #MineralResources, #MiningPartnership, #MiningNews, #CanadaMining, #HighGradeGold, #HighGradeCopper

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Good morning from London where the FTSE 100 jumped over 100 points as trading got underway on Wednesday.

Among the risers was HSBC after the bank posted higher-than-expected second-quarter profit and unveiled a £3 billion share buyback.

Housebuilder Taylor Wimpey also gained early on, as a reiterated target to build up to 10,000 homes this year appeared to overshadow a drop in interim profit.

Rio Tinto climbed after reporting a 3% improvement in first-half pre-tax earnings and reassuring demand from China was expected to remain robust.

GSK fell in the meantime, despite hiking full-year profit guidance following a 13% jump in second-quarter sales.

#proactiveinvestors #marketreport #ftse #ftse100 #footsie #hsbc #taylorwimpey #riotinto #gsk

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Race Oncology Ltd (ASX:RAC, OTC:RAONF) CEO Dr Daniel Tillett sits down with Jonathan Jackson in the Proactive studio to discuss positive results from an investigator-sponsored Phase 1b/2 trial of RC110 bisantrene for acute myeloid leukaemia (AML). The trial, which included patients with relapsed or refractory AML, demonstrated a 40% response rate, exceeding the efficacy threshold. The open-label trial combined intravenous RC110 bisantrene with chemotherapies clofarabine and fludarabine. Out of the treated patients, five experienced complete responses and one had a partial response, surpassing the goal of at least three complete responses.

Tillett expressed gratitude to Professor Nagler and the Chaim Sheba Medical Centre team for their dedication over the past five years. The team’s efforts have contributed significantly to the historical evidence supporting bisantrene’s efficacy and have spurred further interest among clinicians.

The company plans to initiate a new Phase 1/2 investigator-sponsored trial using RC220 bisantrene, a reformulated version, to meet the high unmet needs of AML patients. Race Oncology is focused on anthracycline combinations, aiming to provide cardio-protection and enhanced anticancer activity in solid tumours, as well as offering low-intensity treatment options for AML.

#ProactiveInvestors #RaceOncology #ASX #AML, #CancerTreatment, #Bisantrene, #ClinicalTrials, #PharmaNews, #OncologyResearch, #ChemoTherapy, #CancerResearch, #HealthNews, #MedicalResearch, #Phase1Trial, #Phase2Trial, #AcuteMyeloidLeukemia, #CancerCare, #MedicalBreakthrough, #Oncology, #Hematology, #DrugDevelopment, #PatientCare

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Latin Resources Ltd (ASX:LRS, OTC:LRSRF) VP of operations in the Americas Tony Greenaway joins Proactive’s Elisha Newell after high-grade drill results confirmed the scale of the Planalto prospect at Latin’s Salinas Lithium Project in Brazil.

Recent drilling results have identified a wide, thick mineralisation core at Planalto, suggesting potential for increased tonnage at the Salinas Project.

This high-grade zone remains open along strike in both directions, down dip, and up plunge to the south-west, indicating an extension closer to the surface.

Greenaway notes that the Planalto prospect shares similar mineralisation characteristics with the company's Colina Deposit, which has long been the subject of Latin’s exploration and development campaign.

So far, Planalto's stacked pegmatite lenses exhibit a shallower dip, but the coarse-grained, spodumene-only mineralisation is consistent with Colina's.

Greenaway reveals the latest drilling has helped the explorer lock onto an up-dip trend in the high-grade core, which will now be the focus of additional drilling.

An initial Planalto resource estimate is scheduled for 2024’s September quarter, pending the receipt of all outstanding assay results.

Big-picture, the latest figures are expected to bring the lithium stock one step closer to the 100-million-tonne resource milestone at the broader Salinas project.

#ProactiveInvestors #LatinResources #ASX #LRS #PlanaltoProspect, #SalinasLithiumProject, #MiningNews, #HighGradeLithium, #MineralResourceEstimate, #LithiumDrilling, #MiningIndustry, #ResourceEstimation, #LithiumMineralisation, #MiningUpdates #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Jindalee Lithium Ltd (ASX:JLL, OTCQX:JNDAF) CEO Ian Rodger joins Jonathan Jackson in the Proactive studio to discuss how the company has achieved battery-grade lithium carbonate producer status at its McDermitt Lithium Project in Oregon, US.

The company produced lithium carbonate with a purity exceeding 99.5% on ore sourced from McDermitt. This test work was conducted in collaboration with Fluor, the lead engineer for the project’s ongoing pre-feasibility study (PFS), at Hazen Research Inc.

This milestone confirms the validation of each step in the processing flowsheet, a critical phase before completing the PFS.

Rodger highlighted the significance of this achievement, noting its importance in reducing risks associated with the processing flowsheet and its potential to supply high-quality lithium chemicals to the US battery value chain. Since the PFS metallurgical test work program began in mid-2023, results have been encouraging, with the PFS expected to be released in Q4 CY2024.

Jindalee’s processing method is similar to Lithium Americas’ Thacker Pass Project, situated 30 kilometres to the south. This similarity suggests comparable geology and validates Jindalee’s decision-making process.

McDermitt contains a substantial lithium resource of 3 billion tonnes at 1,340 parts per million lithium oxide, equating to 21.5 million tonnes of contained lithium carbonate equivalent.

#ProactiveInvestors #JindaleeLithium #ASX #LithiumCarbonate #BatteryGrade #McDermittProject #LithiumMining #OregonLithium #LithiumProduction #BatterySupplyChain #LithiumChemicals #PreFeasibilityStudy #Fluor #HazenResearch #LithiumResources #MiningMilestone #ThackerPass #LithiumAmericas #USBatteryMarket #LithiumOxide #MiningIndustry #GreenEnergy

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Today's CPI data may force the Reserve Bank of Australia (RBA) to choose between maintaining credibility and addressing persistent inflation. Joining Jonathan Jackson in the Proactive studio to talk about potential outcomes is StoneX vice president – Derivatives, Everett O’Chee.

In its June policy update, the RBA board committed to achieving its inflation target with Michelle Bullock emphasising the need for favourable conditions to reach the 2-3% range. Recent trimmed mean inflation rates were 1.2%, 0.8% and 1%, totalling 3%. A quarterly rate above 0.8% would surpass the RBA's forecast of 3.8% for June 2024.

A trimmed mean inflation rate of 1% or higher could necessitate a 25 basis point hike to uphold the RBA's anti-inflation stance. Further hikes may be needed, as a 100bp increase in the cash rate only reduces trimmed mean inflation by 0.20%, according to the RBA's MARTIN model. Inflation has remained high with monthly trimmed mean rates around 4% since December 2023, rising to 4.4% in May. The RBA also faces challenges in maintaining independence from a government implementing tax cuts and fiscal stimulus.

Compared to the US, UK and New Zealand, where rates are above 5%, Australia's peak rate is 4.35%, contributing to inflation rates comparable to developing countries. With an annualised trimmed mean inflation rate of 4.0% and a cash rate target of 4.35%, Australia's real rates are only 0.35%, insufficient to control inflation. The RBA is not yet ready to consider easing rates, unlike its developed market peers. Thus, Wednesday's CPI data is critical for the RBA's credibility ahead of the August 6 meeting.

#ProactiveInvestors #StoneX #CPIData #RBA #Inflation #EconomicPolicy #InterestRates #MonetaryPolicy #AustraliaEconomy #FiscalStimulus #MichelleBullock #TrimmedMean #EconomicOutlook #RateHike #CentralBank #FinancialStability #GlobalEconomy #DevelopedMarkets #FiscalPolicy #EconomicForecast #MarketTrends

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

archTIS Ltd (ASX: AR9) managing director and CEO Daniel Lai sits down with Proactive’s Jonathan Jackson to discuss the latest quarter. For FY24, the company reported a 54% increase in annual revenue, with licensing revenue rising by 58%. Gross margins improved to 60% and gross margin dollars grew by 79%. Operating expenses decreased by 18% and the company generated positive operating cash of $1.4 million, marking a significant improvement from the previous year's outflow. Annual Recurring Revenue (ARR) reached $4.1 million, up 13% from the previous year.

The company secured new contracts with key clients including the Australian Department of Defence, Penten and various global defence suppliers. Notable deals included a $264,000 annual recurring revenue licence fee with Penten and a $775,000 licence renewal with the Australian Department of Defence.

archTIS also retained and expanded its customer base, achieving net revenue growth of 104%. The company appointed Andrew Burns as chief financial officer and co-secretary. Additionally, archTIS won two CyberSecurity Excellence Awards and announced Copper River Technologies as a new US Federal partner.

#ProactiveInvestors #archTIS #ASX #QuarterlyReport #FinancialResults #AnnualRevenue #CybersecurityAwards #Defence #LicensingRevenue #GrossMargin #OperatingCash #ARR #CustomerWins #GlobalExpansion #USFederalPartner #AndrewBurns #CopperRiver #Penten #AustralianDefence #NCProtect #Kojensi #RevenueGrowth

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orders, marking the ninth consecutive quarter of record-breaking order numbers. Zynex reported an 11% year-over-year increase in second-quarter revenue, totaling $49.9 million, and a 20% increase in year-to-date cash flow from operations, reaching $3.2 million.

Sandgaard emphasized the company's ongoing efforts to secure FDA approvals for next-generation devices and expand its product line in pain management. The pain management division saw a significant 20% improvement in orders compared to the previous year, highlighting strong market demand. Looking ahead, Zynex has provided guidance for the third quarter, with revenue expected to reach at least $50.0 million.

Zynex's pain management devices are prescribed for various conditions, from post-surgical recovery to general pain management, by a diverse group of medical professionals, including surgeons, general practitioners, and chiropractors.

.In terms of innovation, Zynex is developing new monitoring devices, including a pulse oximeter based on laser technology for more accurate blood measurements, which could also detect sepsis. This product, along with others in development, positions Zynex to potentially capture significant market share. The company aims to diversify its product portfolio.

#proactiveinvestors #zynexinc #nasdaq #zyxi #healthcare #q2 #finanacials

#ThomasSandgaard, #MedicalDevices, #PainManagement, #HospitalMonitoring, #RevenueGrowth, #SalesForce, #Innovation, #PulseOximeter, #SepsisDetection, #FDAApproval, #Healthcare, #MedicalTechnology, #Chiropractors, #OrthopedicSurgery, #FinancialGrowth, #ProductDevelopment, #MarketExpansion, #NextWave, #MedicalSales#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive revealing the company's preliminary unaudited financial and operational results for the second quarter of 2024, which ended on June 30, 2024. The results showcased a notable revenue increase to $1.2 million, up from $1 million in the first quarter of 2024.

Gappelberg highlighted the company's impressive operational leverage, with a substantial gross profit margin of 70% in Q2, a significant rise from 50% in Q1 and 30% for the entire year of 2023. He attributed this growth to the company's strategic shift towards the Indian market in the fourth quarter of 2023 and advancements in its AI technology. These initiatives are expected to further enhance the company's gross margin, potentially reaching 80% in 2024.

Additionally, Gappelberg announced that Nextech3D.ai recently achieved certification as a 3D modeling partner for Amazon, the world's largest e-commerce platform. This partnership opens new avenues for growth, as Amazon's data suggests that listings featuring 3D models experience a twofold increase in purchase conversions on average. Nextech3D.ai is poised to capitalize on this opportunity, anticipating substantial new business prospects.

#proactiveinvestors #nextech3d.al #otcqx #nexcf #cse #ntar

#Nextech3D #FinancialResults #Q2Earnings #ProfitMargin #RevenueGrowth #AmazonPartnership #3DModeling #HyderabadOffice #TechIntegration #AutoApproval #ROI #ProductConversions #ScalableProduction #FutureExpansion #3Dvs2D #TechMilestone #ECommerce #InvestorUpdate #BusinessGrowth #Technology#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews